C4 Therapeutics
CCCC
$6.74
Share price
4.82%
Change (1 day)
114.65%
Change (1 year)
Categories
C4 Therapeutics (CCCC) - Cash on Hand
Cash on Hand as of December 2023 : $0.25 B
According to C4 Therapeutics's latest financial reports the company has $0.25 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
C4 Therapeutics - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.25 B | -8.14% |
| 2022-12-31 | $0.27 B | -10.71% |
| 2021-12-31 | $0.30 B | -16.79% |
| 2020-12-31 | $0.37 B | 310.48% |
| 2019-12-31 | $90.54 M | 149.37% |
| 2018-12-31 | $36.31 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -17.93% | 🇺🇸 USA |